ASSOCIATION BETWEEN IMPAIRED GLUCOSE-TOLERANCE AND CIRCULATING CONCENTRATION OF LP(A) LIPOPROTEIN IN RELATION TO CORONARY HEART-DISEASE

被引:7
|
作者
FARRER, M
GAME, FL
ALBERS, CJ
NEIL, HAW
WINOCOUR, PH
LAKER, MF
ADAMS, PC
ALBERTI, KGMM
机构
[1] ROYAL VICTORIA INFIRM,DEPT CARDIOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
[3] UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX2 6HE,ENGLAND
[4] UNIV NEWCASTLE UPON TYNE,DEPT MED,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源
BRITISH MEDICAL JOURNAL | 1993年 / 307卷 / 6908期
基金
英国惠康基金;
关键词
D O I
10.1136/bmj.307.6908.832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To examine whether impaired glucose tolerance and raised Lp(a) lipoprotein concentrations are associated in subjects with coronary artery disease. Design-Study of two subject populations, one with and one without symptomatic coronary artery disease. Case-control analysis of patients with impaired glucose tolerance and normal glucose tolerance performed in each subject population independently. Setting-A general practice and a hospital ward in Newcastle upon Tyne. Subjects-517 apparently healthy subjects, 13 with impaired glucose tolerance, and 245 patients who had undergone coronary artery bypass graft surgery 12 months before, 51 with impaired glucose tolerance. Main outcome measures-Serum Lp(a) lipoprotein concentration, plasma glucose concentration before and after oral challenge with 75 g glucose monohydrate, and Lp(a) lipoprotein isoforms. Results-In both the asymptomatic subjects and the subjects with coronary artery disease there was no significant difference between subjects with impaired glucose tolerance and subjects with normal glucose tolerance who were matched for age, sex, and body mass index in serum Lp(a) lipoprotein concentrations (geometric mean 61 (geometric SD 4) mg/l v 83 (5) mg/l for asymptomatic subjects, 175 (3) v 197 (2) for subjects with heart disease), nor was there any difference in the proportion of subjects who had Lp(a) lipoprotein concentrations >300 mg/l (31% v 23% for asymptomatic subjects, 37% v 37% for subjects with heart disease). For both subject groups there was no significant correlation between Lp(a) lipoprotein concentration and plasma glucose concentration after a glucose tolerance test, nor did Lp(a) lipoprotein concentration vary by quintile of glucose concentration after the test. Examination of Lp(a) lipoprotein isoforms in the subjects with coronary artery disease revealed an inverse relation between isoform size and plasma Lp(a) lipoprotein concentration, but there was no evidence that impaired glucose tolerance was associated with particular Lp(a) lipoprotein isoforms. Conclusion-Raised Lp(a) lipoprotein concentrations are not responsible for the association between impaired glucose tolerance and coronary artery disease.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [21] RELATION OF SERUM LIPOPROTEIN(A) CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE TO CORONARY HEART-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    SEED, M
    HOPPICHLER, F
    REAVELEY, D
    MCCARTHY, S
    THOMPSON, GR
    BOERWINKLE, E
    UTERMANN, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (21): : 1494 - 1499
  • [22] BLOOD INSULIN AND GLUCOSE MEASURED IN THE COURSE OF AN ORAL GLUCOSE-TOLERANCE TEST AS CORONARY HEART-DISEASE RISK-FACTORS
    DUCIMETIERE, P
    ESCHWEGE, E
    CLAUDE, JR
    ROSSELIN, EG
    PAPOZ, L
    RICHARD, JL
    PAROI ARTERIELLE-ARTERIAL WALL, 1980, 6 (01): : 56 - 56
  • [23] The relation between impaired glucose tolerance and slow coronary flow
    Binak, Emrah
    Gunduz, Huseyin
    Sahin, Muslum
    Kurtoglu, Nuri
    Dindar, Ismet
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (01) : 142 - 146
  • [24] THE RELATION BETWEEN GLUCOSE-TOLERANCE AND INSULIN BINDING TO CIRCULATING MONOCYTES IN OBESE CHILDREN
    KIDA, K
    WATANABE, N
    FUJISAWA, Y
    GOTO, Y
    MATSUDA, H
    PEDIATRICS, 1982, 70 (04) : 633 - 637
  • [25] INSULIN AND PAI-1 LEVELS DURING ORAL GLUCOSE-TOLERANCE TEST IN PATIENTS WITH CORONARY HEART-DISEASE
    SELJEFLOT, I
    ERITSLAND, J
    TORJESEN, P
    ARNESEN, H
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (03): : 241 - 246
  • [26] APOLIPOPROTEIN(A) PHENOTYPES, LP(A) CONCENTRATION AND PLASMA-LIPID LEVELS IN RELATION TO CORONARY HEART-DISEASE IN A CHINESE POPULATION - EVIDENCE FOR THE ROLE OF THE APO(A) GENE IN CORONARY HEART-DISEASE
    SANDHOLZER, C
    BOERWINKLE, E
    SAHA, N
    TONG, MC
    UTERMANN, G
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03): : 1040 - 1046
  • [27] ASSOCIATION BETWEEN LOW HABITUAL PHYSICAL-ACTIVITY AND IMPAIRED GLUCOSE-TOLERANCE
    ANNUZZI, G
    VACCARO, O
    CAPRIO, S
    DIBONITO, P
    CASO, P
    RICCARDI, G
    RIVELLESE, A
    CLINICAL PHYSIOLOGY, 1985, 5 (01): : 63 - 70
  • [28] PRE-BETA-1 LIPOPROTEIN PHENOMENON IN RELATION TO SERUM-CHOLESTEROL AND TRIGLYCERIDE LEVELS, LP(A) LIPOPROTEIN AND CORONARY HEART-DISEASE
    DAHLEN, G
    ACTA MEDICA SCANDINAVICA, 1974, : 1 - 44
  • [29] LIPIDS AND LIPOPROTEINS AS RISK-FACTORS FOR CORONARY HEART-DISEASE IN MEN WITH ABNORMAL GLUCOSE-TOLERANCE - THE HONOLULU-HEART-PROGRAM
    LAWS, A
    MARCUS, EB
    GROVE, JS
    CURB, JD
    JOURNAL OF INTERNAL MEDICINE, 1993, 234 (05) : 471 - 478
  • [30] COMMENT ON RELATION BETWEEN CHOLESTEROL AND CORONARY HEART-DISEASE
    SCHWANDT, P
    ERNAHRUNGS-UMSCHAU, 1990, 37 (03): : 116 - 118